Can Mounjaro Cause Cancer, and What Side Effects Should You Know About?

Cancer: what is and is not known

The question of whether Mounjaro can cause cancer centres mainly on thyroid C-cell tumours (medullary thyroid carcinoma, or MTC). In animal studies at high doses, tirzepatide — like other GLP-1 receptor agonists — was associated with this tumour type. This has not been demonstrated in human clinical data to date, but because the risk cannot be fully ruled out, the medicine is contraindicated for people with a personal or family history of MTC or certain related conditions. Your prescriber will have assessed this before prescribing. For a deeper look at this specific topic, see our dedicated page on Mounjaro and cancer risk.

Gastrointestinal side effects

The most commonly reported side effects of Mounjaro are gastrointestinal. Nausea, vomiting, diarrhoea, constipation, indigestion, and heartburn are all listed in the official product information. These often relate to the medicine's action on stomach-emptying and appetite pathways (GLP-1 and GIP receptor activity). They tend to be most noticeable around dose changes and frequently ease over time — though this varies from person to person.

Gallbladder and liver

Gallbladder issues, including gallstones, are a recognised concern with GLP-1 class medicines. Rapid changes in weight and eating patterns can affect bile composition and gallbladder motility. There is also ongoing monitoring of liver-related effects. If you experience persistent upper-right abdominal pain, your prescriber should be contacted promptly. You can read more about why Mounjaro may affect the gallbladder.

Cardiovascular symptoms

Some people report palpitations, dizziness, lightheadedness, or chest discomfort. Heart rate can increase on tirzepatide. Chest pain and heart palpitations that are new, severe, or persistent always warrant prompt contact with a healthcare professional — do not try to assess these yourself.

Mood, mental health, and sleep

Reports of mood swings, anxiety, depression, insomnia, and panic attacks exist in post-marketing data and are subjects of ongoing pharmacovigilance. If you notice significant changes in your mood, anxiety levels, or sleep, raise these with your prescriber or doctor rather than attributing them solely to the medicine without clinical input.

Hormonal and reproductive effects

Some people report changes to their menstrual cycle, including irregular or heavier periods, often associated with weight changes rather than a direct drug effect — though the distinction matters clinically. Concerns about fertility or periods should be discussed with your prescriber. See our page on Mounjaro and heavy periods for more context.

Other commonly reported effects

Headaches, migraines, fatigue, tiredness, muscle pain, joint pain, injection-site reactions, burping, flu-like symptoms, blurred vision, and eye discomfort have all been reported. Itching and skin reactions, including spots, are occasionally noted. Hypoglycaemia (low blood sugar) is a particular concern for people also taking insulin or certain diabetes medicines — this requires specific discussion with your prescriber. Yeast infections (thrush) and urinary symptoms have also been reported by some users; see our page on Mounjaro and yeast infections for more information. Any symptom that is severe, sudden, or worrying should be assessed by a healthcare professional promptly. Side effects can also be reported to your national pharmacovigilance scheme (such as the UK Yellow Card scheme or the equivalent in your country) and to your prescriber, in line with the medicine's black triangle ▼ monitoring status. For a broader overview of how Mounjaro works and why these effects occur, visit our guide on how Mounjaro works.

One of the most practical things you can do when experiencing any new or changing symptom on Mounjaro is to record it — when it started, how severe it felt, and how long it lasted. GLP Trackr's side-effect tracker is built for exactly this: log symptoms as they happen, note their intensity, and build a picture over time so you can see whether something is improving, worsening, or correlating with dose changes.

That log becomes genuinely useful at prescriber appointments. Rather than trying to recall three months of how you felt, you can share a clear, dated record. The app's doctor report feature pulls this information together in a format designed for those conversations.

Beyond side effects, the daily check-in captures mood, energy, sleep, and food noise — the broader picture of how you're feeling on the medicine, not just isolated symptoms. Many people find patterns they wouldn't otherwise have noticed.

A note on serious symptoms: GLP Trackr is a tracking tool, not a medical service. If you experience chest pain, severe or persistent vomiting, signs of an allergic reaction, significant vision changes, or any symptom that feels urgent, contact a healthcare professional without delay. The app helps you record — it does not replace clinical assessment.

Always follow your prescriber or doctor's guidance on your treatment; they know your full medical history and are best placed to assess any symptom in context.

If keeping track of how you feel on Mounjaro sounds useful, GLP Trackr is free to try for seven days — available on the App Store and Google Play. Log symptoms, spot patterns, and go to your next appointment prepared.